Patents
Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
11/2011
11/15/2011US8058426 Phosphorus-containing compounds and uses thereof
11/10/2011WO2011138293A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
11/10/2011US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/09/2011CN101454296B Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/01/2011US8048825 Haloalkylsulfonanilide derivatives or salt thereof, herbicide comprising the derivatives as active ingredient, and use of the herbicide
10/2011
10/27/2011WO2011132712A1 Novel hydroxamic acid derivative
10/20/2011WO2011127794A1 Chiral cyclic beta-amino aryl butyric acid derivatives, their preparation methods and methods for preparation of chiral beta-amino aryl butyric acid derivatives via them
10/18/2011US8039600 Monoclonal antibodies
10/18/2011US8039458 HIV integrase inhibitors
10/12/2011EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011CN102212041A Chiral cyclic beta-amino aryl butyric acid derivatives and preparation method thereof
10/11/2011CA2524640C 2, 3, 4, 5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
09/2011
09/29/2011US20110237567 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
09/29/2011US20110237566 Therapeutic Macrolide Compounds and Their Use
09/28/2011EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
09/21/2011CN101360725B Solid formulations
09/20/2011US8022208 Benzene derivative or salt thereof
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/06/2011US8012943 Antibacterial agents
08/2011
08/23/2011US8003784 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
08/17/2011CN101535283B Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
08/16/2011US7998951 treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid
08/11/2011US20110196147 Inhibitors of histone deacetylase
08/09/2011US7994161 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
08/02/2011US7989617 Crown ether derivatives
07/2011
07/28/2011US20110183963 Amino Acid Conjugates of Quetiapine, Process for Making and Using the Same
07/19/2011US7981880 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors
07/14/2011US20110172233 Sonic hedgehog modulators
07/13/2011EP2343286A1 Dibenzo[b,f][1,4]oxazepine derivatives as inhibitors of histone deacetylase
07/07/2011WO2011082076A1 Amino acid conjugates of quetiapine, process for making and using the same
07/07/2011US20110166172 Rapamycin Carbonic Ester Analogues, Pharmaceutical Compositions, Preparations and Uses Thereof
07/07/2011CA2785846A1 Amino acid conjugates of quetiapine, process for making and using the same
06/2011
06/28/2011US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/23/2011US20110152246 Novel inhibitors of hepatitis c virus replication
06/23/2011US20110152245 Substituted benzamides
06/21/2011CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes
06/16/2011US20110144101 Macrocyclic compounds useful as pharmaceuticals
06/14/2011CA2494962C Tyrosine kinase inhibitors
06/09/2011WO2011067219A1 Diphenyl azepine derivatives as monoamine reuptake inhibitors
06/09/2011CA2776724A1 Diphenyl azepine derivatives as monoamine reuptake inhibitors
06/03/2011CA2724303A1 Synergic combination of analgesic compounds
05/2011
05/31/2011CA2493390C A process for production of high-purity enamines
05/26/2011US20110123644 Macrocyclic compounds and methods of treatment
05/24/2011US7947688 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
05/24/2011US7947676 Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents
05/11/2011CN102056908A New terpenes and macrocycles
04/2011
04/21/2011US20110092582 New Terpenes And Macrocycles
04/14/2011US20110086858 Compounds for the Treatment of Hepatitis C
04/13/2011EP2308861A1 Macrocyclic compounds useful as pharmaceuticals
04/06/2011EP1828151B1 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
04/06/2011EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof
03/2011
03/31/2011WO2010127088A3 Intramolecular azide-alkyne cycloaddition
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011034051A1 Novel cyclic squaramide derivatives
03/24/2011CA2772689A1 Glycine compound
03/09/2011EP2292621A1 Vasopressin v1a antagonists
02/2011
02/24/2011US20110046112 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors
02/23/2011EP2285788A1 New terpenes and macrocycles
02/08/2011CA2480940C Non-steroidal progesterone receptor modulators
02/03/2011WO2011012987A1 Pharmaceutical composition of isoniazid
02/02/2011CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
01/2011
01/12/2011EP1880215B1 Compositions and methods for detection of sirolimus
01/12/2011CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
01/12/2011CN101941920A Aromatic ketone oxime photoinitiator compound
01/04/2011US7863277 antipsychotic (ziprasidone and quetiapine) encapsulated in cyclodextrin, and a dermatologically acceptable carrier consisting of ethoxy diglycol, lecithin soya, isopropyl palmitate, poloxamer and water; schizophrenia; Bipolar disorders
12/2010
12/28/2010US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/15/2010CN101918389A Inhibitors of histone deacetylase
12/14/2010US7851439 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection
12/01/2010EP2256119A1 Vasopressin V1a antagonists
11/2010
11/25/2010WO2010133180A1 Poly-iodo benzene compound, preparation method and use thereof
11/24/2010CN101891696A Poly-iodo acromatic compound and preparation method and application thereof
11/18/2010US20100292210 Novel Compounds for A-Beta-Related Pathologies
11/18/2010US20100292179 Target
11/17/2010CN101889000A Dibenzoazepine and dibenzooxazepine TRPA1 agonists
11/04/2010WO2010127088A2 Intramolecular azide-alkyne cycloaddition
11/04/2010WO2010126551A1 Potent conjugates and hydrophilic linkers
11/03/2010EP1496838B1 Substituted amides
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010US20100273773 Dibenzoazepine and dibenzooxazepine trpa1 agonists
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/21/2010WO2010119906A1 Haloalkylsulfonanilide derivative
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010CA2757729A1 Haloalkylsulfonanilide derivative
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/14/2010WO2010118208A1 Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
10/05/2010US7807828 derivatives of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine for modulating sleep disorder; side effect reduction
09/2010
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/28/2010CA2429267C Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/22/2010EP2229364A2 Dibenzoazepine and dibenzooxazepine trpa1 agonists
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/07/2010CA2485349C A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
08/2010
08/26/2010US20100216770 Inhibitors of the Interaction Between MDM2 and P53
08/24/2010US7781422 Macrocyclic indole compounds, e.g., 16-cyclohexyl-3,6-dimethyl-17-phenyl-4,5,6,7,8,9-hexahydro-1H-13,15-(ethanediylidene)pyrrolo[2,1-f][1,2,7,10,13]thiatetraazacyclohexadecine-2,12(3H)-dione 10,10-dioxide; hepatitis C virus polymerase inhibitors
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 21